News Quantified

MBOT – microbot medical inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference

Microbot Medical (MBOT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

Microbot Medical (MBOT) had its "sell (d-)" rating reaffirmed by Weiss Ratings.

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System

Form 8-K Microbot Medical Inc. For: Apr 14

Form 8-K Microbot Medical Inc. For: Apr 13

Form 424B5 Microbot Medical Inc.

Form 8-K Microbot Medical Inc. For: Apr 10

Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Wilson David James

Top News Gainers

12/23 Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures 74.9%

9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%

12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%

2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%

1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%

12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%

3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%

9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%

10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%

7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%

Top News Decliners

12/27 Form 424B5 Microbot Medical Inc. -24.0%

12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%

12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%

9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%

1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%

4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%

12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%

12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%

10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%

5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day